Cargando…
Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study
BACKGROUND/OBJECTIVES: Prolactin-releasing peptide (PrRP) has a potential to decrease food intake and ameliorate obesity, but is ineffective after peripheral administration. We have previously shown that our novel lipidized analogs PrRP enhances its stability in the circulation and enables its centr...
Autores principales: | Mikulášková, Barbora, Holubová, Martina, Pražienková, Veronika, Zemenová, Jana, Hrubá, Lucie, Haluzík, Martin, Železná, Blanka, Kuneš, Jaroslav, Maletínská, Lenka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851428/ https://www.ncbi.nlm.nih.gov/pubmed/29339795 http://dx.doi.org/10.1038/s41387-017-0015-8 |
Ejemplares similares
-
Impact of novel palmitoylated prolactin-releasing peptide analogs on metabolic changes in mice with diet-induced obesity
por: Pražienková, Veronika, et al.
Publicado: (2017) -
Palmitoylated prolactin-releasing peptide treatment had neuroprotective but not anti-obesity effect in fa/fa rats with leptin signaling disturbances
por: Mráziková, Lucia, et al.
Publicado: (2022) -
Prolactin-Releasing Peptide: Physiological and Pharmacological Properties
por: Pražienková, Veronika, et al.
Publicado: (2019) -
Palmitoylation of Prolactin-Releasing Peptide Increased Affinity for and Activation of the GPR10, NPFF-R2 and NPFF-R1 Receptors: In Vitro Study
por: Karnošová, Alena, et al.
Publicado: (2021) -
Age-related metabolic and neurodegenerative changes in SAMP8 mice
por: Pačesová, Andrea, et al.
Publicado: (2022)